Prevalence Of Homogenous And Non Homogenous Leukoplakia In A Private Dental Hospital
Md Sohaib Shahzan1, Manjari Chaudhary2*, Madhulaxmi Marimuthu3
1 Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
2 Senior Lecturer, Department of Oral Medicine, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
3 Professor, Department of Oral Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University,Chennai, India.
*Corresponding Author
Dr Manjari Chaudhary,
Senior Lecturer, Department of Oral Medicine, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
Tel: + 91 7044455554
E-mail: manjaric.sdc@saveetha.com
Received: August 16, 2020; Accepted: August 27, 2020; Published: August 30, 2020
Citation:Md Sohaib Shahzan, Manjari Chaudhary, Madhulaxmi Marimuthu. Prevalence Of Homogenous And Non Homogenous Leukoplakia In A Private Dental Hospital. Int J
Dentistry Oral Sci. 2020;S4:02:0016:88-92. doi: dx.doi.org/10.19070/2377-8075-SI02-040017
Copyright: Manjari Chaudhary© 2020. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Leukoplakia is thickened,white patches inside the mouth, mostly non-cancerous premalignant lesions. it'sclassified in two
main types: Homogenous and Non homogenous types. Homogenous leukoplakia may be auniform white area, flat appearance
and texture although there could also besuperficial irregularities. Non homogenous leukoplakia has non uniform
appearance,surface texture is irregular-flat, nodular or exophytic. The aim is to find the prevalence of homogenous and non
homogenous leukoplakia in patients visiting Saveetha dental college and hospitals. It is a retrospective study. We reviewed
patient records and analysed the infoof 86000 patients between June 2019 and March 2020.The results were analysed using
chi-square test. The statistical software used is SPSS by IBM. In total 96 cases were confirmed.Prevalence was found to be
0.23% and was more common in males than in females. Leukoplakia was more prevalent within the age groupbetween 40-
80 years. Homogenous type is more prevalent than non homogenous type.Within the bounds of study it is concluded that
leukoplakia features a prevalence of 0.23% and it most ordinarily affects men older than 40 years. Homogenous type is more
prevalent than non homogenous type.
2.Introduction
3.Materials and Method
4.Results And Discussion
5.Conclusion
6.References
Keywords
Leukoplakia; Homogenous; Non Homogenous; Prevalence; Pre Malignant Lesion.
Introduction
Leukoplakia is thickened,white patches inside the mouth ,mostly
non cancerous premalignant lesion [4]. The patches cannot be
scraped off. The World Health Organization (WHO) defined leukoplakia
as “A predominantly white patch or plaque that can't be
characterized clinically or pathologically as the other disorder.
Leukoplakia may be a descriptive term that ought to only be applied
after other possible causes are ruled out [23, 32]. Tissue biopsy
generally shows increased keratin build up with or without
abnormal cells, but isn't diagnostic [6, 33]. In recent years there
has been development of varied lesions, developmental anomalies
and various malignancies [7]. Other conditions which will appear
similar include yeast infections, lichen planus, and keratosis due
to repeated minor [28, 33]. The lesions from a yeast infection can
typically be rubbed off while those of leukoplakia cannot [23].
Classification
Oral Leukoplakia is classified in two main types: homogeneous
type which appears as a flat white lesion and non-.homogeneous
type [34].
Homogenous leukoplakia
Homogenous leukoplakia (also termed "thick leukoplakia") is
typically well defined white patch of uniform, flat appearance
and texture, although there could also be superficial irregularities
[4, 20]. Homogenous leukoplakia is typically slightly elevated
compared to surrounding mucosa, and sometimes features a fissured,
wrinkled or corrugated surface texture, with the feel generally consistent throughout the entire lesion [4, 27]. This term has
no implications on the dimensions of the lesion, which can be
localized or extensive [4, 35]. When homogenous leukoplakia is
palpated, it's going to feel leathery, dry, or like cracked mud.
Non-homogenous leukoplakia
Non-homogenous leukoplakia may be a lesion of non-uniform
appearance. the colour could also be predominantly white or a
mixed white and red. The surface texture is irregular compared
to homogenous leukoplakia, and should be flat (papular), nodular
[26, 16]. Non-homogeneous leukoplakias have a greater risk of
cancerous changes than homogeneous leukoplakias [16].
Etiology
The exact underlying explanation for leukoplakia is essentially unknown,
but it's likely multifactorial, with the most factor being the
utilization of tobacco [23, 31, 24, 35]. Other risk factors for formation
inside the mouth include smoking, excessive alcohol, and
use of betel nuts [33, 5]. It's far more common among smokers
than among non-smokers [34].
Signs and symptoms
Most cases of leukoplakia cause no symptoms, but infrequently
there could also be discomfort or pain [4, 25]. The precise appearance
of the lesion is variable. Leukoplakia could also be white,
whitish yellow or green [17]. The dimensions can range from a little
area to much larger lesions [2]. The foremost common sites affected
are the buccal mucosa, the labial mucosa and therefore the
alveolar mucosa, although any mucosal surface within the mouth
could also be involved [4, 8, 6, 25]. The clinical appearance, including
the surface texture and color, could also be homogenous
or nonhomogeneous. Some signs are generally related to a better
risk of cancerous changes.
Treatment planning
At the primary , the ceasing of the risk activities like smoking is
suggested. Further, the histopathological evaluation is required .
The degree of dysplasia will guide the selection of the treatment.
The surgical procedure can use conventional surgery or laser ablation,
electrocauterization, or cryosurgery [17, 29]. The medical
treatment uses local and systemic chemopreventive agents like
vitamin A , systemic beta carotene, lycopene , ketorolac , local
bleomycin [17, 21]. Another possible choice is an attitude of "wait
and see" to keep oral leukoplakia under clinical and histological
surveillance with frequent visits and biopsies without other treatment.
This follow-up can observe an early malignant transformation
and subsequent specific treatment [17, 7, 22, 6, 18]. This
study throws in some light that focuses to find out the prevalence
of leukoplakia among south Indian population – a primary step in
understanding the disorder.Thus the aim of the study is to analyse
the prevalence of homogenous and non homogenous leukoplakia
in patients visiting Saveetha Dental College.
Materials and Methods
The study was administered in an institutional setting with the
advantage being an outsized data availability and therefore the disadvantages
being assessment of patients belonging to an identical
geographic location. The ethical approval was provided by the
Institutional ethical committee. The study included all the patients
visiting Saveetha Dental College and hospitals (SDC) from June
2019-February 2020. Patients with clinically diagnosed leukoplakia
were filtered and demographics of the info were studied. The
collected data was subjected to photographic-cross verification.
Inclusion criteria was patients with clinically diagnosed leukoplakia.
Cases which didn't fall into this inclusion criteria were excluded
from the study.The study was supported non probability
convenience sampling. To minimise the sampling bias, all the case
sheets of patients with clinically diagnosed leukoplakia were reviewed
and included.
We reviewed patient records and analysed the info of 86000 patients
between June 2019 and March 2020.The data collected was
statistically analysed using SPSS version 20.0. Descriptive statistics
and chi square tests were performed and graphs were plotted
to reach final results.
Results And Discussion
The prevalence of leukoplakia varies round the world, but generally
speaking it's not an uncommon condition [14]. Reported
prevalence estimates range from less than 1% to more than 5%
within the general population [30]. Leukoplakia is therefore the
foremost common premalignant lesion that happens within the mouth [11]. In areas of the world where smokeless tobacco
use is common, there's a higher prevalence [13]. within the year
1992, Gupta et al. found a good range of leukoplakia prevalence
in various populations. In India, leukoplakia was found in 0.2%
and 4.9% of the population [12]. Bánóczy 1983 found that the
adult population prevalence varied between 0.6% and 3.6% [1].
Martorell-Calatayud et al. found the prevalence of Oral leukoplakia
ranges from 0.4% to 0.7% of the population [19]. [11] Feller
and Lemmer estimated the prevalence of Oral leukoplakia ranged
from 0.5% to 3.46%, %. Brouns et al. found the prevalence of
Oral Leukoplakia is approximately 2% [3]. The present study
shows the prevalence rate of 0.23%.There are multiple various
prevalence rate across the world as there are conditions which can
have certain changes with the changing geographic location and
race/ethnicity. This might have been due to the definitive diagnostic
criteria getting used within the other studies.
Bánóczy revealed the prevalence of leukoplakia within the age-group of 51-60 years [1]. Espinoza 2003 reported the higher prevalence
after 50 years aged [10]. Liu et al. conducted study on 218
patients and he found that peak incidence was the fifth decade of
life [15]. All the results being almost like the results of this study.
Bánóczy revealed the prevalence of leukoplakia more in males
than in females [1]. Espinoza 2003 reported the higher prevalence
present in men [10]. Downer and Petti found leukoplakia to be
significantly more prevalent in males [9]. All the results being almost
like the results of this study.
Brouns et al. 2013 during a study found that homogeneous leukoplakia
was more prevalent than non-homogeneous leukoplakia
[3]. The result's almost like the results of this study. Since homogenous
leukoplakia are multifactorial the higher incidence of
it occurring becomes difficult to be explained. It might be due to
variation within the availability of tobacco products, consumption
of tobacco with or without calcium hydroxide, duration and
frequency of tobacco products combined with alcohol usage
within the Indian population [1].
This study wasn't free from all limitations-it had its share of limitations.
The criteria (inclusion and exclusion) were termed accordingly
and no standardisation criteria was used. The results obtained
were highly subjective. No information regarding the other
systemic factors and factors not included within the exclusion
and exclusion criteria was considered within the research. due to
this,few patients who might suffer from leukoplakia could have
been excluded.
Figure 1. Bar graph depicting the prevalence of leukoplakia among male and female.X-axis shows the status of leukoplakia and Y-axis shows the number of patients in both genders. Blue bar represents male patients and green bar represents female patients. It shows that leukoplakia is more prevalent in males (95.79%).
Figure 2. Bar graph depicting the Prevalence of leukoplakia among age groups.X-axis shows the status of leukoplakia and Y- axis shows the number of patients in the age groups. Blue bar are patients of age group 0-40 years and green bar are patients of age group 41-80 years. It shows that leukoplakia is more prevalent in patients of age group 41-80 years (74.74%).
Figure 3. Bar chart depicting the prevalence of leukoplakia in patients visiting private dental hospital in 1 year. X axis represents the presence of leukoplakia in patients and Y axis represents the number of patients visiting private dental hospital in one year's time. White bar represents leukoplakia present in patients and the brown bar represents leukoplakia absent in patients. It shows that the prevalence of leukoplakia is 0.23%.
Figure 4. Bar graph depicting the association between gender and prevalence of homogenous and non homogenous leukoplakia in male and female .X-axis shows the types of leukoplakia - homogeneous and nonhomogeneous and Y-axis shows the number of patients in both genders. Blue bar represents male patients and green bar represents female patients. It shows that both homogenous(73.68%) and nonhomogeneous (22.11%) leukoplakia are more prevalent in males. Association between homogenous and non homogenous leukoplakia among males and females and chi square test was done with p value 0.219, where p>0.05 ( statistically insignificant).
Figure 5. Bar chart depicting the association between age and prevalence among homogenous and non homogenous leukoplakia in male and female.X-axis shows the types of leukoplakia - homogeneous and nonhomogeneous and Y- axis shows the number of patients in the age groups. Blue bars are patients of age group 0-40 and green bars are patients of age group 41-80. It shows that both homogenous(54.74%) and non homogenous leukoplakia(20%) are more prevalent in patients of age group 41-80 years. Association between age and prevalence among homogenous and non-homogenous leukoplakia in males and females was done using chi square test, p value 0.318, where p>0.05 (statistically insignificant).
Conclusion
Within the limits of present study, it can be concluded that leukoplakia
most commonly affects men older than 40 years and has
a prevalence of 0.23%. Homogenous type is more common than
non-homogenous type of leukoplakia. Further studies should be
done with a large sample size and should focus on other factors
such as medication intake, nutritional status as a next step.The
patient should be made aware of this condition which will help in
early diagnosis thus we can improve the quality of life of patients
and create a better society.
References
- Bánóczy J. Oral leukoplakia and other white lesions of the oral mucosa related to dermatological disorders. J Cutan Pathol. 1983 Aug;10(4):238-56. Pubmed PMID: 6350389.
- Brennan PA. Soames’ and Southam's Oral Pathology (2018, ). Edited by: Robinson M Hunter K Pemberton M Sloan P ed. Published by Oxford University Press, UK.
- Brouns ER, Baart JA, Bloemena E, Karagozoglu H, van der Waal I. The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18(1):e19-26. Pubmed PMID: 23085711.
- Greenberg VJ. Burket's oral medicineDiagnosis and Treatment.
- Chaitanya NC, Muthukrishnan A, Krishnaprasad CMS, Sanjuprasanna G, Pillay P, Mounika B. An Insight and Update on the Analgesic Properties of Vitamin C. J Pharm Bioallied Sci. 2018 Jul-Sep;10(3):119-125. Pubmed PMID: 30237682.
- Chaitanya NC, Muthukrishnan A, Babu DBG, Kumari CS, Lakshmi MA, Palat G, et al. Role of Vitamin E and Vitamin A in Oral Mucositis Induced by Cancer Chemo/Radiotherapy- A Meta-analysis. J Clin Diagn Res. 2017 May;11(5):ZE06-ZE09. Pubmed PMID: 28658926.
- Choudhury P, Panigrahi RG, Maragathavalli, Panigrahi A, Patra PC. Vanishing roots: first case report of idiopathic multiple cervico-apical external root resorption. J Clin Diagn Res. 2015 Mar;9(3):ZD17-9. Pubmed PMID: 25954713.
- Dharman S, Muthukrishnan A. Oral mucous membrane pemphigoid - Two case reports with varied clinical presentation. J Indian Soc Periodontol. 2016 Nov-Dec;20(6):630-634. Pubmed PMID: 29238145.
- Downer MC, Petti S. Leukoplakia prevalence estimate lower than expected. Evid Based Dent. 2005;6(1):12; author reply 13-4. Pubmed PMID: 15789044.
- Espinoza I, Rojas R, Aranda W, Gamonal J. Prevalence of oral mucosal lesions in elderly people in Santiago, Chile. J Oral Pathol Med. 2003 Nov;32(10):571-5. Pubmed PMID: 14632931.
- Feller L, Lemmer J. Oral Leukoplakia as It Relates to HPV Infection: A Review. Int J Dent. 2012;2012:540561. Pubmed PMID: 22505902.
- Gupta PC, Mehta FS, Pindborg JJ, Bhonsle RB, Murti PR, Daftary DK, et al. Primary prevention trial of oral cancer in india: a 10-year follow-up study. J Oral Pathol Med. 1992 Nov;21(10):433-9. Pubmed PMID: 1460581.
- Hassona Y, Scully C, Almangush A, Baqain Z, Sawair F. Oral potentially malignant disorders among dental patients: a pilot study in Jordan. Asian Pac J Cancer Prev. 2014;15(23):10427-31. Pubmed PMID: 25556487.
- JamesWD, BergerTG, ElstonDM. Andrews’ Diseases of the Skin: Clinical Dermatology. Saunders Elsevier.2006.
- Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010 Dec 16;10:685. Pubmed PMID: 21159209.
- Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016 Jul 29;7(7):CD001829. Pubmed PMID: 27471845.
- Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008 Feb;37(2):63-9. Pubmed PMID: 18197849.
- . Maheswari TNU, Venugopal A, Sureshbabu NM, Ramani P. Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review. Ci Ji Yi Xue Za Zhi. 2018 Apr-Jun;30(2):55-60. Pubmed PMID: 29875583.
- Martorell-Calatayud A, Botella-Estrada R, Bagán-Sebastián JV, Sanmartín- Jiménez O, Guillén-Barona C. La leucoplasia oral: definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica [Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach]. Actas Dermosifiliogr. 2009 Oct;100(8):669-84. Spanish. Pubmed PMID: 19775545.
- Misra SR, Shankar YU, Rastogi V, Maragathavalli G. Metastatic hepatocellular carcinoma in the maxilla and mandible, an extremely rare presentation. Contemp Clin Dent. 2015 Mar;6(Suppl 1):S117-21. Pubmed PMID: 25821363.
- Muthukrishnan A, Bijai Kumar L. Actinic cheilosis: early intervention prevents malignant transformation. BMJ Case Rep. 2017 Mar 20;2017:bcr2016218654. Pubmed PMID: 28320702.
- Muthukrishnan A, Bijai Kumar L, Ramalingam G. Medication-related osteonecrosis of the jaw: a dentist's nightmare. BMJ Case Rep. 2016 Apr 6;2016:bcr2016214626. Pubmed PMID: 27053542.
- NevilleBW. Oral and Maxillofacial Pathology. Saunders/Elsevier.2009.
- Patil SR, Maragathavalli G, Araki K, Al-Zoubi IA, Sghaireen MG, Gudipaneni RK, et al. Three-rooted mandibular first molars in a Saudi Arabian population: A CBCT study. Pesquisa brasileira em odontopediatria e clinica integrada. 2018 Aug 27;18(1):4133.
- Rohini S, Kumar VJ. Incidence of dental caries and pericoronitis associated with impacted mandibular third molar–A radiographic study. Research Journal of Pharmacy and Technology. 2017 Apr 1;10(4):1081.
- Scully C. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. Elsevier Health Sciences.2013.
- Steele JC, Clark HJ, Hong CH, Jurge S, Muthukrishnan A, Kerr AR, et al. World Workshop on Oral Medicine VI: an international validation study of clinical competencies for advanced training in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Aug;120(2):143-51.e7. pubmed PMID: 25861956.
- Subashri A, Maheshwari TU. Knowledge and attitude of oral hygiene practice among dental students. Research Journal of Pharmacy and Technology. 2016 Nov 1;9(11):1840.
- Subha M, Arvind M. Role of magnetic resonance imaging in evaluation of trigeminal neuralgia with its anatomical correlation. Biomedical and Pharmacology Journal. 2019 Mar 25;12(1):289-96.
- Tanaka T, Tanaka M, Tanaka T. Oral carcinogenesis and oral cancer chemoprevention: a review. Patholog Res Int. 2011;2011:431246. Pubmed PMID: 21660266.
- Underner M, Perriot J, Peiffer G. Le snus [Smokeless tobacco]. Presse Med. 2012 Jan;41(1):3-9. French. Pubmed PMID: 21840161.
- Venugopal A, Uma Maheswari TN. Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review. J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):474-479. Pubmed PMID: 27721614.
- Villa A, Woo SB. Leukoplakia-A Diagnostic and Management Algorithm. J Oral Maxillofac Surg. 2017 Apr;75(4):723-734. Pubmed PMID: 27865803.
- Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575-80. Pubmed PMID: 17944749.
- Muthukrishnan A, Warnakulasuriya S. Oral health consequences of smokeless tobacco use. Indian J Med Res. 2018 Jul;148(1):35-40. Pubmed PMID: 30264752.